Telmilok Plus 40 mg+12.5 mg (Tablet)
Unit Price: ৳ 12.50 (3 x 10: ৳ 375.00)
Strip Price: ৳ 125.00
Medicine Details
Category | Details |
---|---|
Generic | Telmisartan hydrochlorothiazide |
Company | Square pharmaceuticals plc |
Indications
- treatment of hypertension
- lower blood pressure
- reduce risk of cardiovascular events
- can be used alone or with other antihypertensive agents
Pharmacology
- Telmisartan blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II
- specifically blocks the binding of angiotensin II to the AT1 receptor
- does not inhibit ACE or bind to other hormone receptors or ion channels
- Hydrochlorothiazide affects renal tubular mechanisms of electrolyte reabsorption
- increases excretion of sodium salt and chloride
- reduces plasma volume
- increases plasma renin activity
- increases aldosterone secretion
- reduces potassium loss
- mechanism of antihypertensive effect is not fully understood
Dosage & Administration
- Initiate with Telmisartan monotherapy 80 mg or Hydrochlorothiazide 25 mg once daily
- Telmisartan and Hydrochlorothiazide 80 mg/12.5 mg once daily
- Dose can be titrated up to 160 mg/25 mg after 2 to 4 weeks
- may be administered with other antihypertensive drugs
Interaction
- Caution with aliskiren, digoxin, lithium, other high blood pressure medicines, NSAIDs, corticosteroids, ACE blockers, angiotensin II receptor blockers
- may interfere with certain laboratory tests
Contraindications
- hypersensitivity to Telmisartan, Hydrochlorothiazide, or any other component
- do not co-administer with aliskiren in diabetic patients
Side Effects
- dizziness
- drowsiness
- tired feeling
- flushing
- back pain
- nausea
- diarrhea
- stomach pain
- allergy
- fever
- leg pain
- chest pain
- insomnia
- elevations of liver enzymes
- leg cramps
- myalgia
- dermatitis
- weakness
- gastric irritation
- photosensitivity
- urticaria
- muscle spasm
- restlessness
Pregnancy & Lactation
- Pregnancy Category D
- discontinue as soon as pregnancy is detected
- potential adverse effects on neonate
- presence in human milk
- decision on nursing based on importance of the drug to the mother
Precautions & Warnings
- medical history consideration
- monitoring blood sugar
- affect on potassium levels
- dizziness caution
- report prolonged diarrhea or vomiting
- adequate fluid intake to prevent dehydration
Use in Special Populations
- safety and effectiveness not established in pediatric patients
- cautious dose selection for elderly patients
- initiate under close medical supervision in patients with biliary obstructive disorders or hepatic insufficiency
- not recommended in severe renal impairment
- no dose adjustment in mild or moderate renal impairment
Overdose Effects
- manifestations of overdosage: hypertension, dizziness, tachycardia, bradycardia, hypokalemia, hypochloremia, hyponatremia, dehydration
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Keep out of the reach of children
- Keep in a cool and dry place
- Protect from light
Related Brands
- Mitosan Plus 40 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Mitosan Plus 80 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Telcardis Plus 40 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Telcardis Plus 80 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Arbitel Plus 40 mg+12.5 mg (Tablet) - aci-limited